SAN CLEMENTE, Calif.–(BUSINESS WIRE)–CareTrust REIT, Inc. (NYSE:CTRE) announced today that it plans to release its second quarter 2024 financial results after the U.S. markets close on Thursday, August 1, 2024. Representatives of CareTrust REIT’s management team will host a conference call to discuss the results and other current matters the following day. Conference Call CareTrust … [Read more…]
OKLAHOMA CITY–(BUSINESS WIRE)–#Medibase–The law firm of Federman & Sherwood has initiated an investigation into The Medibase Group, Inc. (“Medibase”) on behalf of Self Regional Healthcare with respect to their recent data breach. On or around May 28, 2024, Medibase contacted Self Regional Healthcare to inform them of a cybersecurity incident that occurred on January 26, … [Read more…]
The Board is a group of established clinicians, researchers, industry advisors, and thought leaders dedicated to the mental health field LOS ANGELES–(BUSINESS WIRE)–SimplePractice, a top-rated EHR and practice management platform with more than 200,000 solo and group health and wellness practitioners, has announced the launch of its customer advisory board, SimpleCircle. This group of 15 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Highly Potent API Market: Analysis and Forecast, 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The Asia-Pacific highly potent API market is projected to reach $25.68 billion by 2033 from $7.49 billion in 2023, growing at a CAGR of 13.11% during the forecast period 2023-2033. The Asia-Pacific highly potent API market has … [Read more…]
LEXINGTON, Mass.–(BUSINESS WIRE)–Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its second quarter 2024 financial results before the market opens on Thursday, August 8, 2024. Agenus executives will host a conference call and webcast at 8:30 a.m. ET that morning to … [Read more…]
The positive opinion marks the latest step towards marketing authorization in the European Union (EU), with a final decision from the European Commission (EC) now pending. If approved, delgocitinib cream will be the first topical treatment specifically indicated for adults with moderate to severe CHE for whom topical corticosteroids are inadequate or inappropriate. The positive … [Read more…]
Proceeds to support Phase 1 clinical trials for two proprietary programs, and to advance two additional programs to IND approval Company to expand R&D efforts to discover additional development candidates for rare endocrine diseases and obesity, including those targeting Class B GPCRs Portfolio expansion to include a focus on agonistic GPCR antibodies GHENT, Belgium–(BUSINESS WIRE)–Confo … [Read more…]
BRANFORD, Conn.–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: AZITRA, INC. ANNOUNCES CLOSING OF $10.0 MILLION PUBLIC OFFERING Azitra, Inc. (NYSE American: AZTR) (“Company”), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the closing of its previously announced public … [Read more…]
BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 8, 2024. Individuals interested in participating in the call should dial (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) using conference ID number and event … [Read more…]
Chamberlain University expands its Practice Ready. Specialty Focused.™ program to include the Critical Care Nursing Course in partnership with the American Association of Critical-Care Nurses, preparing students to enter the high-demand specialty. CHICAGO–(BUSINESS WIRE)–Adtalem Global Education (NYSE: ATGE), the number one provider of healthcare education in the U.S.1, and the American Association of Critical-Care Nurses … [Read more…]
